DexCom
DXCM
DXCM
508 hedge funds and large institutions have $19.9B invested in DexCom in 2019 Q4 according to their latest regulatory filings, with 118 funds opening new positions, 160 increasing their positions, 167 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4% less repeat investments, than reductions
Existing positions increased: 160 | Existing positions reduced: 167
1.2% less ownership
Funds ownership: 398.98% → 397.78% (-1.2%)
52% less call options, than puts
Call options by funds: $145M | Put options by funds: $299M
Holders
508
Holding in Top 10
12
Calls
$145M
Puts
$299M
Top Buyers
| 1 | +$232M | |
| 2 | +$228M | |
| 3 | +$152M | |
| 4 |
Renaissance Technologies
New York
|
+$141M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$126M |
Top Sellers
| 1 | -$373M | |
| 2 | -$196M | |
| 3 | -$127M | |
| 4 |
Coatue Management
New York
|
-$67.6M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$63.9M |